Dr. Kristen N. Rice, MD

Dr. Rice practices at Medical Oncology Associates of San Diego a Medical Group Inc in San Diego, California.

Dr. Rice's NPI, 1558542845, was assigned on November 15, 2007. Dr. Rice graduated from University of Colorado Anschutz Medical Campus in 2005. Dr. Rice holds California license A98229.

Dr. Rice's primary practice is Medical Oncology Associates of San Diego a Medical Group Inc, at 5555 Reservoir Dr, San Diego, CA 92120 in San Diego County. The practice phone is (858) 637-7888.

Dr. Rice's primary practice is Medical Oncology Associates of San Diego a Medical Group Inc in San Diego, California. Dr. Rice is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Rice to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rice practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rice's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rice is board certified in hematology by the American Board of Internal Medicine. Dr. Rice is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Rice treats.

CMS data shows 3,431 Medicare services from Dr. Rice across 11 procedure codes in 2024, for 231 Medicare patients. Medicare paid $111,652 for them. Every service was in an office.

CMS counts 231 Medicare patients who saw Dr. Rice in 2024. The largest group is 75 to 84, with 109 patients. 73% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rice's median patient age at 73, with 67% women.

In 2024, Dr. Rice wrote 762 Medicare Part D claims for 129 patients. 73% of them were for generic drugs. CMS names the drug for 528 of them, across 23 drugs with 11 or more claims each, at $848,271 in total drug cost. In 2023, CMS named 542 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Rice for performance year 2024, reported as part of a group. Dr. Rice accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rice as offering telehealth.

Dmand AI links 2 papers to Dr. Rice in 2010. Dr. Rice's most frequent co-authors are Catriona H. Jamieson, MD, PhD and Jean S. Kutner, MD.

Dmand AI links Dr. Rice to 1 clinical trial. Conditions studied include Melanoma and Nevi and Melanomas.

CMS Open Payments shows 13 general payments to Dr. Rice from 12 drug and device companies from 2016 to 2025. Education make up the largest share, 57% of the total. Medical Device Business Services, Inc. paid the most, $325.

Dmand AI lists 2 awards for Dr. Rice, most recently Top Specialty Care Provider for Patient Experience in 2023.

Dr. Rice graduated from University of Colorado Anschutz Medical Campus in 2005. Dr. Rice is a member of ASCO, ASH and CMA.

Dr. Rice is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.